Patent 11123331
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Active provider: Google · gemini-2.5-flash
Proceedings on file (0)
All PTAB activity →AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.
Current assignee: Veloxis Pharmaceuticals AS
No PTAB proceedings on file. This patent has not been challenged via IPR, PGR, or CBM. The absence is itself a signal — well-asserted patents eventually attract IPRs. The LLM analysis below may surface filings the ODP feed hasn’t indexed yet.
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Proceedings overview
There are no AIA trial proceedings on file for US Patent 11,123,331 as of the most recent ingest by the USPTO Open Data Portal, nor did web searches reveal any older or recently filed proceedings. This indicates that the patent has not been subjected to IPR, PGR, or CBM challenges at the PTAB.
Strategic summary
As of today, May 30, 2026, all claims of US Patent 11,123,331 remain untested by AIA trial proceedings at the PTAB. This means there are no canceled or sustained claims through these specific administrative processes. The estoppel landscape is entirely open, as no petitioner has challenged the patent at the PTAB, thus no prior art grounds have been precluded by § 315(e)(2) for future petitioners. There is no pattern of PTAB challenges or appeals associated with this patent.
Recommended next steps
There are no active PTAB proceedings or final decisions to track for US Patent 11,123,331. The absence of PTAB activity is a notable signal; for a patent issued in September 2021, the lack of challenges could suggest several things, including that it has not yet been heavily asserted, that potential challengers have found stronger avenues, or that the claims are perceived as robust against IPR/PGR challenges. If facing assertion of this patent, all prior art grounds remain available for potential PTAB petitions.
Generated 5/30/2026, 12:45:42 PM